Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Physiomics ( (GB:PYC) ) has shared an update.
Physiomics plc has announced the details of its upcoming Annual General Meeting (AGM), scheduled for 18 November 2025. Shareholders will receive either printed copies or notifications to access the AGM notice and the company’s Annual Report online. This announcement underscores Physiomics’ commitment to maintaining transparency and engagement with its stakeholders, which is crucial for its continued success and industry positioning.
Spark’s Take on GB:PYC Stock
According to Spark, TipRanks’ AI Analyst, GB:PYC is a Underperform.
Physiomics’ stock score is primarily impacted by significant financial instability, including declining revenues and negative profit margins. Technical indicators reinforce a bearish outlook. While recent corporate events suggest potential growth pathways, current valuation issues and financial challenges remain significant obstacles.
To see Spark’s full report on GB:PYC stock, click here.
More about Physiomics
Physiomics plc is a leading company in mathematical modelling, data science, and biometrics, primarily supporting the development of new therapeutics and personalized medicine solutions. The company combines expertise in Modelling & Simulation, Biostatistics, Data Science, and Bioinformatics to assist biotech and pharma companies in streamlining their drug development processes. Their services include deriving insights from diverse data to optimize research design across various stages of drug development, with notable clients including Merck KGaA, Astellas, and Bicycle Therapeutics.
Average Trading Volume: 2,784,936
Technical Sentiment Signal: Strong Sell
Current Market Cap: £1.29M
For detailed information about PYC stock, go to TipRanks’ Stock Analysis page.